How to Optimize Rate Control in Clinical Atrial Fibrillation Management

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1299-1301

  Andrade, Jason G ^a,b   Gin, Kenneth ^a   Kerr, Charles ^a   Deyell, Marc W ^a   Chakrabarti, Santabhanu ^a   Ramanathan, Krishnan ^a   Krahn, Andrew D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIGOXIN; DRONEDARONE; IVABRADINE; SOTALOL;

ADRENERGIC ACTIVITY; ARTICLE; CONTROL STRATEGY; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE FUNCTION; HUMAN; MONOTHERAPY; QUALITY OF LIFE; SINUS RHYTHM;

ATRIAL FIBRILLATION; DISEASE MANAGEMENT; HUMANS; MORBIDITY; THROMBOEMBOLISM; WORLD HEALTH;

EID: 84884590482     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.01.015     Document Type: Article

References (5)

1. Stiell I.G., Macle L. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol 2011, 27:38-46.
2. Gillis A.M., Verma A., Talajic M., Nattel S., Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol 2011, 27:47-59.
3. Goldman S., Probst P., Selzer A., Cohn K. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol 1975, 35:651-655.
4. Wyse D.G. It's health care delivery, stupid: implementing the new Canadian Cardiovascular Society atrial fibrillation treatment guidelines. Can J Cardiol 2011, 27:14-18.
5. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. NEngl J Med 1997, 336:525-533.